Concepedia

Michael Bordonaro

MB

Statistics

Publications

28

Citations

1.2K

H-Index

20

Active since

1999

Affiliations

Geisinger Commonwealth School of Medicine(Current)

Yale University

Yale Cancer Center

Albert Einstein College of Medicine

Marywood University

Michael Bordonaro is an author at Geisinger Commonwealth School of Medicine specializing in cancer cell signaling, cell signaling, and colorectal cancer.

ORCID

Publications per year

1999–2021

28

Publications

28

Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.

John M. Mariadason, Michael Bordonaro, Fauzia Aslam et al. · PubMed · 2001 · 176 citations

, , +16

Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate

Darina L. Lazarova, Michael Bordonaro, Rocco Carbone et al. · International Journal of Cancer · 2004 · 101 citations · Full text

, , +17

Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.

Michael Bordonaro, John M. Mariadason, Fauzia Aslam et al. · PubMed · 1999 · 87 citations

, , +17

The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors

Michael Bordonaro, Darina L. Lazarova, Alan C. Sartorelli · Experimental Cell Research · 2007 · 81 citations

, , +10

A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells

Michael Bordonaro, Shruti Tewari, Catherine E. Cicco et al. · PLoS ONE · 2011 · 64 citations · Full text

, , +17

1–5 of 28